Osmotic activity of plasma in patients with multiple myeloma undergoing plasmapheresis

被引:0
作者
Movshev, BE [1 ]
Kalinin, NN [1 ]
Patrov, MM [1 ]
Petrova, VI [1 ]
Zhuravlev, VS [1 ]
Zakharova, ES [1 ]
Khoroshko, ND [1 ]
机构
[1] Russian Acad Med Sci, Hematol Res Ctr, Moscow, Russia
关键词
osmotic activity; plasmapheresis; multiple myeloma;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To control safety and efficiency of therapeutic plasmapheresis (PA) by osmolality, colloido-osmotic pressure (COP), total protein concentration before and after the procedure in patients with paraproteinemic hemoblastosis. Material and methods. 20 patients with multiple myeloma have undergone 42 PA procedures conducted by two techniques: continuous flow centrifugation on blood fractioners or intermittent centrifugation of blood in plastic containers. The removed plasma volume averaged 1/3 (group 1) or 2/3 of the plasma volume (group 2). The removed protein reached 62-197 g. Isotonic sodium chloride solution and/or reopolyglucin (20-60 g) replaced the removed plasm. Total protein concentration was measured colorimetrically in biuretic reaction, plasma osmolality - cryoscopically and COP - on Knauer osmometer. Results. PA leads to a short decline in osmolality (97.0-99.1%), of total protein concentration (82.8-78.6%) and of COD (79.2% in replacement with saline and 90.2% in replacement with dextran). During recovery after the procedure plasma osmotic activity and protein concentration return to the baseline. Conclusion. In elimination of 1/3 of plasma volume and crystalloid infusion, hemodilution promotes release of abnormal proteins from the tissues into the circulation and thereafter removal then: from the organism. In removal of 1/2 and more of plasma volume, COP demans correction made by administration of colloids, e.g. solution of low molecular dextran. There is a potential danger of COD lowering several hours after PA due to different speed of dextran elimination and mobilization of protein reserve.
引用
收藏
页码:57 / 60
页数:4
相关论文
共 18 条
  • [1] PLASMA-VOLUME NOMOGRAMS FOR USE IN THERAPEUTIC PLASMA-EXCHANGE
    BUFFALOE, GW
    HEINEKEN, FG
    [J]. TRANSFUSION, 1983, 23 (04) : 355 - 357
  • [2] CAREY JS, 1970, SURG GYNECOL OBSTETR, V131, P679
  • [3] RENAL-FUNCTION IN PATIENTS WITH MULTIPLE-MYELOMA
    DEFRONZO, RA
    COOKE, CR
    WRIGHT, JR
    HUMPHREY, RL
    [J]. MEDICINE, 1978, 57 (02) : 151 - 166
  • [4] Draper N. R., 1966, APPL REGRESSION ANAL
  • [5] EXPERIENCE WITH LARGE VOLUME PLASMAPHERESIS IN MALIGNANT PARAPROTEINEMIA AND IMMUNE DISORDERS
    ISBISTER, JP
    BIGGS, JC
    PENNY, R
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1978, 8 (02): : 154 - 164
  • [6] KALININ NN, 1996, TERAPEVT ARKH, V7, P62
  • [7] KOSS MN, 1974, LAB INVEST, V31, P131
  • [8] PROTEIN AND COLLOID OSMOTIC-PRESSURE CHANGES WITH ALBUMIN AND OR SALINE REPLACEMENT DURING PLASMA-EXCHANGE
    LASKY, LC
    FINNERTY, EP
    GENIS, L
    POLESKY, HF
    [J]. TRANSFUSION, 1984, 24 (03) : 256 - 259
  • [9] LENTNER C, 1984, GEIGY SCI TABLES, V3, P47
  • [10] Lundsgaard-Hansen P., 1986, CURR STUD HEMATOL BL, V53, P1